AIDSVu Releases New Data Showing Significant Inequities in PrEP Use Among Black and Hispanic Americans
July 29, 2022 12:30 ET
|
AIDSVu
ATLANTA, July 29, 2022 (GLOBE NEWSWIRE) -- Today, AIDSVu released the first-ever publicly available state-level PrEP use data and maps by race/ethnicity from 2012 to 2021, showing that while PrEP...
Les données sur Trogarzo(MD) présentées à la conférence AIDS 2022 par Theratechnologies démontrent la possibilité d’améliorer les schémas thérapeutiques
July 28, 2022 11:19 ET
|
Theratechnologies
Une nouvelle sous-analyse des données sur des patients ayant participé à un essai clinique sur Trogarzo démontre que la suppression virale à long terme n’est pas influencée par des agents...
Theratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Regimens
July 28, 2022 11:19 ET
|
Theratechnologies
New sub-analysis on Trogarzo clinical trial patients demonstrates that long-term viral suppression is not influenced by partially active agents. Predictive pharmacokinetic modelling shows that new...
'I Can't Wait' is the Campaign Theme for World Hepatitis Day 2022
July 28, 2022 00:15 ET
|
World Hepatitis Alliance
LONDON, England, July 28, 2022 (GLOBE NEWSWIRE) -- Today, World Hepatitis Day (WHD) launches with the campaign theme 'I Can't Wait'. On WHD, the World Hepatitis Alliance (WHA) joins together with...
Societal CDMO Selected To Provide Tech Transfer And Manufacturing Services To Support Clinical Development Of An Oral Solid Dose Product In Europe
July 20, 2022 07:00 ET
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., July 20, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving...
WCG Cares Unveils Rebrand, Changes Name to Catalyst Global
July 14, 2022 12:00 ET
|
Catalyst Global
CARLSBAD, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- WCG Cares, an international non-profit organization committed to increasing access to critical sexual and reproductive health (SRH) products and...
Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV
July 11, 2022 07:00 ET
|
Immunocore Holdings Limited
PRESS RELEASE Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV IMC-M113V, T cell receptor bispecific, targets an HIV Gag antigen Single Ascending Dose portion of Phase...
With 5.9% CAGR, HIV Drugs Market Size worth USD 45.58 Billion in 2028
June 28, 2022 07:36 ET
|
Fortune Business Insights
Pune, India, June 28, 2022 (GLOBE NEWSWIRE) -- The global HIV drugs market is set to gain traction from the increasing development of antiretroviral therapy to make it a first long-acting injectable...
35 Years since its first panels were stitched, The AIDS Memorial Quilt remains a powerful teaching tool for health action, remembrance and social justice
June 14, 2022 10:02 ET
|
National AIDS Memorial
San Francisco, CA, June 14, 2022 (GLOBE NEWSWIRE) -- It has been 35 years since the first panels of the AIDS Memorial Quilt were stitched together, sparking a national movement for action, justice...
Exavir Therapeutics announces publication of preclinical data for ultra-long-acting dolutegravir prodrug XVIR-120
June 09, 2022 07:00 ET
|
Exavir Therapeutics
Ultra-long-acting plasma pharmacokinetics and biodistribution to tissues of interest demonstrated in three species Injections were well tolerated with no adverse findings in preliminary toxicology...